ANL 15.55 Decreased By ▼ -0.65 (-4.01%)
ASC 14.10 Decreased By ▼ -0.53 (-3.62%)
ASL 20.00 Decreased By ▼ -0.04 (-0.2%)
BOP 8.70 Increased By ▲ 0.15 (1.75%)
BYCO 7.28 Decreased By ▼ -0.25 (-3.32%)
FCCL 17.00 Decreased By ▼ -0.50 (-2.86%)
FFBL 23.00 Decreased By ▼ -0.15 (-0.65%)
FFL 14.89 Decreased By ▼ -0.36 (-2.36%)
FNEL 7.08 Decreased By ▼ -0.27 (-3.67%)
GGGL 16.45 Decreased By ▼ -0.70 (-4.08%)
GGL 28.10 Decreased By ▼ -1.85 (-6.18%)
HUMNL 6.13 Increased By ▲ 0.17 (2.85%)
JSCL 20.55 Decreased By ▼ -0.13 (-0.63%)
KAPCO 28.61 Decreased By ▼ -0.38 (-1.31%)
KEL 3.40 Decreased By ▼ -0.08 (-2.3%)
MDTL 2.15 Increased By ▲ 0.04 (1.9%)
MLCF 32.75 Decreased By ▼ -0.85 (-2.53%)
NETSOL 101.40 Decreased By ▼ -4.60 (-4.34%)
PACE 4.30 Decreased By ▼ -0.03 (-0.69%)
PAEL 26.50 Decreased By ▼ -1.45 (-5.19%)
PIBTL 8.40 Decreased By ▼ -0.30 (-3.45%)
POWER 6.75 Decreased By ▼ -0.15 (-2.17%)
PRL 16.31 Decreased By ▼ -0.87 (-5.06%)
PTC 9.26 Decreased By ▼ -0.04 (-0.43%)
SILK 1.43 Decreased By ▼ -0.01 (-0.69%)
SNGP 42.50 Increased By ▲ 0.17 (0.4%)
TELE 16.40 Decreased By ▼ -0.05 (-0.3%)
TRG 128.62 Decreased By ▼ -7.16 (-5.27%)
UNITY 28.55 Decreased By ▼ -1.35 (-4.52%)
WTL 2.29 Decreased By ▼ -0.11 (-4.58%)
BR100 4,628 Decreased By ▼ -40.11 (-0.86%)
BR30 20,295 Decreased By ▼ -596.96 (-2.86%)
KSE100 44,680 Decreased By ▼ -141.4 (-0.32%)
KSE30 17,485 Decreased By ▼ -36.1 (-0.21%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,280
1124hr
Pakistan Cases
1,265,047
66324hr
1.66% positivity
Sindh
465,819
Punjab
437,974
Balochistan
33,128
Islamabad
106,469
KPK
176,886
Markets

Nikkei falls as market heavyweights offset gains in drugmakers

  • Kawasaki Kisen Kaisha, up 5.38%, was the biggest gainer on Nikkei, followed by Daiichi Sankyo.
08 Jun 2021

TOKYO: Japan's stock index Nikkei changed course and inched down on Tuesday, as losses in market heavyweights offset gains in drugmakers after Eisai Co's Alzheimer drug received US nod.

Nikkei share average inched down 0.11% to 28,987.58 by 0235 GMT, while the broader Topix edged up 0.06% to 1,962.07.

"The news on Eisai has given a boost to its peers as well as the overall market," said Shoichi Arisawa, general manager of the investment research department at IwaiCosmo Securities.

"Investors are also scooping up Japanese shares which lagged behind their global peers as prospects of an economic recovery has brightened amid a rollout of COVID-19 vaccines."

But Nikkei's earlier gains were snapped as investors were cautious ahead of the US consumer price index (CPI) report this week and the US central bank's meeting next week, market participants said.

US regulators on Monday approved a drug jointly developed by Eisai and Biogen Inc's as the first treatment to attack a likely cause of Alzheimer's disease.

Drug makers were the top gainers among the Tokyo Stock Exchange's 33 industry subindexes, with Eisai remaining untraded as buy orders far exceeded sell orders.

Daiichi Sankyo jumped 4.58% and Astellas Pharma rose 1.83%.

Losses in index heavyweights, however, weighed on the markets, with global start-up investor SoftBank Group down 1.56% and air-conditioner maker Daikin Industries losing 2.9%.

Kawasaki Kisen Kaisha, up 5.38%, was the biggest gainer on Nikkei, followed by Daiichi Sankyo.

Sumitomo Metal Mining , down 3.41%, was the largest decliner on the index, followed by Oji Holdings losing 2.37% and Daikin Industries.

There were 130 advancers on the Nikkei index against 86 decliners.

Comments

Comments are closed.